tiprankstipranks

BioTech ETFs

BioTech ETFs are a type of exchange-traded fund that tracks a basket of stocks of biotechnology companies. These ETFs can be a good way to invest in the biotechnology sector, which is a rapidly growing and innovative sector. This page compares the performance, fees, and other features of some of the most popular BioTech ETFs. By comparing these ETFs, you can find the one that best meets your investment goals.
Compare up to 20 stocks or ETFs

Comparison Results

Symbol
ETF Name
Price & Change
Expense Ratio
AUM
1 Year %
Smart Score
Follow
iShares Biotechnology ETF
137.29
-0.05 (-0.04%)
0.45%$7.10B+6.77%
SPDR S&P BIOTECH ETF
92.59
-0.02 (-0.02%)
0.35%$6.86B+8.94%
First Trust NYSE Arca Biotechnology Index Fund
153.44
+0.17 (+0.11%)
0.56%$1.12B-1.07%
Invesco Dynamic Biotechnology & Genome ETF
65.01
-0.406 (-0.62%)
0.58%$258.10M+5.91%
ALPS Medical Breakthroughs ETF
34.53
-0.155 (-0.45%)
0.50%$107.68M+9.81%
Virtus LifeSci Biotech Products ETF
56.68
-0.159 (-0.28%)
0.79%$19.55M+6.76%

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
IBB
iShares Biotechnology ETF
137.34
8.42
6.53%
XBI
SPDR S&P BIOTECH ETF
92.61
6.89
8.04%
FBT
First Trust NYSE Arca Biotechnology Index Fund
153.27
-2.73
-1.75%
PBE
Invesco Dynamic Biotechnology & Genome ETF
65.42
3.46
5.58%
SBIO
ALPS Medical Breakthroughs ETF
34.69
2.91
9.16%
BBP
Virtus LifeSci Biotech Products ETF
56.84
3.13
5.83%
Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

BioTech ETFs Stocks Latest News

Read the latest stock news and analysis from the TipRanks news team.

BioTech ETFs Stocks - FAQ

Which BioTech ETFs stocks have a "Strong Buy" analyst rating?
These BioTech ETFs stocks currently have a "Strong Buy" analyst rating consensus:
iShares Biotechnology ETF - Strong Buy, based on 1811 analyst ratings, 1380 Buy, 401 Hold, and 30 Sell.
    SPDR S&P BIOTECH ETF - Strong Buy, based on 1362 analyst ratings, 1060 Buy, 284 Hold, and 18 Sell.
      First Trust NYSE Arca Biotechnology Index Fund - Strong Buy, based on 454 analyst ratings, 312 Buy, 128 Hold, and 14 Sell.
        Invesco Dynamic Biotechnology & Genome ETF - Strong Buy, based on 386 analyst ratings, 284 Buy, 94 Hold, and 8 Sell.
          ALPS Medical Breakthroughs ETF - Strong Buy, based on 753 analyst ratings, 620 Buy, 125 Hold, and 8 Sell.
            Virtus LifeSci Biotech Products ETF - Strong Buy, based on 691 analyst ratings, 490 Buy, 181 Hold, and 20 Sell.
              Are BioTech ETFs stocks overpriced?
              iShares Biotechnology ETF's stock price is currently $137.29, and its average 12-month price target is $207.12.
                SPDR S&P BIOTECH ETF's stock price is currently $92.59, and its average 12-month price target is $202.06.
                  First Trust NYSE Arca Biotechnology Index Fund's stock price is currently $153.44, and its average 12-month price target is $233.99.
                    Invesco Dynamic Biotechnology & Genome ETF's stock price is currently $65.01, and its average 12-month price target is $101.34.
                      ALPS Medical Breakthroughs ETF's stock price is currently $34.53, and its average 12-month price target is $80.52.
                        Virtus LifeSci Biotech Products ETF's stock price is currently $56.68, and its average 12-month price target is $110.16.
                          Which BioTech ETFs stocks pay dividends?
                          iShares Biotechnology ETF does not currently pay dividends.
                            SPDR S&P BIOTECH ETF does not currently pay dividends.
                              First Trust NYSE Arca Biotechnology Index Fund does not currently pay dividends.
                                Invesco Dynamic Biotechnology & Genome ETF does not currently pay dividends.
                                  ALPS Medical Breakthroughs ETF does not currently pay dividends.
                                    Virtus LifeSci Biotech Products ETF does not currently pay dividends.

                                      Latest News​

                                      Michael ByrneOMFL ETF: This Outperformer Has a Perfect 10 Smart Score
                                      Radhika SaraogiQQQ ETF Update, 5/16/2024 
                                      Shalu SarafSPY ETF Update, 5/15/2024  
                                      Radhika SaraogiSPGP, VOT: 2 ETFs with Over 10% Upside Potential, According to Analysts
                                      Michael ByrneXLU ETF: The Formerly Sleepy Utilities Sector Has Awakened
                                      Radhika SaraogiQQQ ETF Update, 5/14/2024 
                                      Radhika SaraogiSPY ETF Update, 5/13/2024 
                                      Michael ByrneAIRR: Stellar Returns, And Not Your Average ETF
                                      Radhika SaraogiQQQ ETF Update, 5/10/2024 
                                      Radhika SaraogiVUG and VHT: 2 “Strong Buy” Vanguard ETFs with Upside Potential, According to Analysts
                                      Shalu SarafSPY ETF Update, 5/9/2024  
                                      Shalu SarafQQQ ETF Update, 5/8/2024  
                                      Michael ByrneVDC: Strong and Steady Consumer Staples ETF
                                      Shalu SarafSPY ETF Update, 5/7/2024  
                                      Paul HoffmanMarket Volatility Spikes Amid Conflicting Economic Signals
                                      Shalu SarafQQQ ETF Update, 5/6/2024  
                                      Michael ByrneCOPJ ETF: Is Now the Time to Buy Junior Copper Stocks?
                                      Kailas SalunkheThis Week in Lithium: An Oil Giant’s Hunt for Lithium and Albemarle’s Woes
                                      Shalu SarafSPY ETF Update, 5/3/2024  
                                      Michael ByrneFLKR: Unlocking Value in South Korea’s Undervalued Market

                                      Popular Stocks

                                      Company
                                      Price & Change
                                      Follow
                                      Nvidia
                                      Apple
                                      Microsoft